
IBA – ACQUISITION OF OWN SHARES
Trade date | Shares purchased | Average price | Min price | Max price | Buyback amount |
08/04/2025 | 7,000 | 10.30 € | 10.22 € | 10.46 € | 72,132.20 € |
08/04/2025 | 100,000 | 10.44 € | 10.44 € | 10.44 € | 1,044,000.00 € |
09/04/2025 | 10,000 | 9.76 € | 9.69 € | 9.92 € | 97,550.00 € |
10/04/2025 | 10,000 | 9.83 € | 9.67 € | 10.56 € | 98,305.00 € |
11/04/2025 | 10,000 | 9.70 € | 9.62 € | 9.85 € | 96,954.00 € |
14/04/2025 | 7,000 | 10.03 € | 9.93 € | 10.08 € | 70,207.20 € |
TOTAL | 144,000 | 10.27 € | 9.62 € | 10.56 € | 1,479,148.40 € |
These transactions include the purchase of a block of 100,000 shares at a price of 10.44 EUR/share, which was executed on April 8th, 2025 at 09:16:13 AM on the central order book of Euronext Brussels (XBRU).
The total number of shares purchased under this program therefore amounts to 280,017 since this is the third week of execution. As a result, the current situation with respect to treasury shares (held directly by IBA SA and indirectly through its subsidiary IBA Investments SRL) is the following :
Shares | Voting rights | ||
IBA Investments SRL | 51,973 | 103,946 | |
IBA SA | 593,596 | 660,019 | |
Total - Treasury shares | 645,569 | 763,965 | |
Total - Issued shares | 30,282,218 | 40,514,366 | |
Treasury shares in % | 2.13% | 1.89% |
About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at:
Contact person
IBA
Thomas Pevenage,
Investor Relations
...
Attachment
-
250414-Buyback-IBA-EN


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment